Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Deciphering the role of microbiome-fibroblast crosstalk in intestinal immune development, homeostasis and inflammation

Project description

Microbiome-fibroblast crosstalk in the intestine

The bacteria, fungi and other microorganisms living in our intestine, known as microbiota, are known to play a key role in intestinal immunity. However, the underlying mechanisms remain unclear. Intestinal fibroblasts (iFBs), originally considered to be structural cells, are now emerging as key immune regulators capable of directly sensing microbial signals. With the support of the Marie Skłodowska-Curie Actions programme, the FibroBiomeCrosstalk project aims to investigate how the crosstalk between the microbiome and iFBs shapes immunity during development, homeostasis and inflammation. Researchers will undertake single cell and spatial transcriptomic analysis to identify microbial sensing pathways in iFBs and determine their role in inflammatory bowel disease (IBD). Project findings have the potential to guide future strategies for IBD management.

Objective

The microbiome plays an essential role in intestinal immune development, homeostasis and inflammatory bowel diseases (IBD), however, our understanding of the underlying mechanisms by which it regulates these processes remains incomplete. Intestinal fibroblasts (iFB) are a heterogeneous population of tissue-resident cells increasingly recognized for their role in immune regulation. In preliminary studies, the host group and a collaborator found that human and mouse iFB express distinct arrays of microbial sensors and immune mediators and that iFB transcription is altered in germ-free mice. In my proposed project, I will combine state-of-the-art high dimensional flow cytometry, single cell (sc)RNA-seq, CITE-seq, spatial transcriptomics and bioinformatics analysis with animal models and analysis of human intestinal datasets to test the hypothesis that microbiome-iFB crosstalk plays a key role in intestinal immune system development, homeostasis and inflammation. Microbiome impact on iFB and intestinal immune system development will be assessed throughout the weaning period by treating mice with broad-spectrum antibiotics and/or antifungals. The importance of direct iFB-microbiome sensing for immune homeostasis and inflammation will be assessed as above as well as in dextran sulphate sodium (DSS)-induced colitis model in mice whose FB are deficient in either the Toll-like receptor signaling adaptor Myd88 or the C-type lectin receptor-Syk mediated antifungal response adaptor CARD9. Finally, translational aspects will be assessed through extensive bioinformatics analysis of iFB scRNA-seq datasets to map microbial sensor expression in human iFB subsets, evidence of downstream signaling through such sensors and their alterations in IBD. Collectively, this project uses a multi-systems approach to obtain novel insights into the importance of microbiome-iFB interactions in intestinal immune system homeostasis and disease with potential relevance for IBD management.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

KOBENHAVNS UNIVERSITET
Net EU contribution
€ 247 553,28
Address
NORREGADE 10
1165 KOBENHAVN
Denmark
Region
Danmark Hovedstaden Byen København
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data